Compare Adaptive Biotechnologies Corp (ADPT) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Adaptive Biotechnologies Corp trades at $24.9 (market cap $4.04B), while Direxion Daily Semiconductor Bear 3X Shares trades at $39.88. Which is the better fit depends on your goals.
| ADPT | SOXS | |
|---|---|---|
Market Cap | $4.04B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $25.45 | $1.49K |
52-Week Low | $12.30 | $32.50 |
Enterprise Value | $4.10B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $24.94, down 2.0% today but near its 52-week high. The stock shows a bullish technical trend with improving fundamentals, including 49% MRD revenue growth and narrowing losses. A recent 4:1 reverse stock split and planned business separation aim to unlock value, with analyst consensus leaning bullish.
Outlook is cautiously optimistic due to strong revenue growth and margin expansion, but risks persist from ongoing net losses and competitive pressures. The stock offers potential upside to the $25.50 consensus target if execution continues improving, yet volatility may remain until profitability is achieved.
SOXS, a leveraged inverse ETF tracking the semiconductor sector, trades at $39.56, down 12.5% in the past 24 hours amid a bearish technical signal. The stock split 1:10 on July 15, 2026, and paid a $0.04 dividend in June 2026. Technical indicators show oversold conditions with an RSI of 26.30, while moving averages signal a downtrend.
The outlook remains highly speculative due to SOXS's inverse leverage structure, which amplifies losses in rising markets. Risks include semiconductor sector volatility and the ETF's decay from daily rebalancing. It suits only aggressive traders betting against chip stocks, not long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
